Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
25 and 50 mg diclofenac K film coated immediate release tablets More
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
Adhesive Patch of 90 sq. cm. and containing as active ingredient 100 mg. of ketoprofen for the local treatment of traumatic injuries and extra-articular rheumatism More
25mg dosage strenght for the OTC market in film coated tablets More
The First Line of Therapy in Severe Migraine Attacks More
4 and 8 mg Ondansetron ready for submission in EU (exp. Q4/08) using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
5 and 10 mg Donepezil are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
12,5 mg diclofenac K film coated immediate release tablets (OTC) More
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 1068 pages - $2,495
Sep 2011 - 97 pages - $3,500
Mar 2011 - 6 pages - $500
Oct 2010 - 53 pages - $1,000
Mar 2011 - 107 pages - $3,500
Jan 2011 - 80 pages - $1,500
Nov 2007 - 173 pages - $1,860
Mar 2009 - 20 pages - $995
Mar 2009 - 20 pages - $995
Aug 2011 - 87 pages - $1,500
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Age-related disorders (other)
- Amyotrophic lateral sclerosis
- CNS (other)
- Neurodegenerative disorders
- Neurological
- Pain
- Psychiatric
- Subarachnoid hemorrhage
- Traumatic brain injury
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us